Skip to content

Clinical Study of Regeneration on Larynx Soft Tissue Guided by Functional Collagen Scaffold

The Safety and Efficacy Assessment of Functional Collagen Scaffold Transplantation for Larynx Soft Tissue Regeneration

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02754284
Enrollment
20
Registered
2016-04-28
Start date
2015-12-31
Completion date
2020-06-30
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vocal Cord Dysfunction

Brief summary

This study is carried out to explore the short-term and long-term efficacy of the functional collagen scaffold in guiding laryngeal soft tissue regeneration.

Interventions

Autologous abdominal fat will be injected into vocal cord beneath mucous under surgery microscope.

Injectable collagen scaffold combined with adipose derived stem cells that are isolated from abdominal adipose tissue will be injected into vocal cord beneath mucous under surgery microscope.

Sponsors

Peking Union Medical College
CollaboratorOTHER
Chinese Academy of Sciences
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Age of 18-65 years old, male or female 2. Severe unilateral vocal cord injury and poor closure of the glottis 3. Disease course was more than 1 year 4. At least two GRBAS scores reach 2 points or more 5. The subjects have read and fully understood the research notes, signed informed consent

Exclusion criteria

1. Over speaking professionals, such as teachers, shop assistants. 2. With vital organ dysfunction, such as heart, lung, liver or kidney. 3. Pregnant or lactating women, or in preconception period. 4. Allergic to various drugs. 5. Difficult to be followed-up or cooperate long-termly. 6. Participated in other clinical trials in the last 3 months. 7. With progressive severe disease. 8. Alcoholics or drug addicts. 9. Unable to execute clinical study protocol due to severe mental disorders or lingual barriers 10. With inevitable circumstances of voice damage. 11. Any other unsuitable conditions for the study.

Design outcomes

Primary

MeasureTime frame
Change in subjective auditory perception score1 week, 2 week, 1,3,6,12 month after intervention

Secondary

MeasureTime frame
Objective acoustic evaluation (Jitter)1 week, 2 week, 1,3,6,12 month after intervention
Objective acoustic evaluation (Shimmer)1 week, 2 week, 1,3,6,12 month after intervention
Objective acoustic evaluation (Normalized noise energy)1 week, 2 week, 1,3,6,12 month after intervention
Objective acoustic evaluation(Maximum phonation time)1 week, 2 week, 1,3,6,12 month after intervention
Change in voice handicap index (VHI) scale1 week, 2 week, 1,3,6,12 month after intervention
Physical status assessment of vocal cords (Closing test of vocal cords)1 week, 2 week, 1,3,6,12 month after intervention
Physical status assessment of vocal cords (Morphology of vocal cords)1 week, 2 week, 1,3,6,12 month after intervention
Change in volume of vocal cords1 week, 2 week, 1,3,6,12 month after intervention
Physical status assessment of vocal cords(Motor test of vocal cords)1 week, 2 week, 1,3,6,12 month after intervention

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026